Press release
Theranostics Market Outlook: Emerging Technologies and Regional Insights - Major Companies are GE Healthcare, Jubilant Pharmova Limited & Theragnostics Ltd.
Theranostics Market
The Theranostics Market is extensively analyzed in the latest study by DataM Intelligence, delivering a well-rounded assessment backed by reliable statistics, historical data, and strategic insights. This report profiles leading industry players, examining their product offerings, pricing strategies, financial health, and growth initiatives. It offers a clear perspective on market dynamics, competitive landscape, and emerging trends that are set to shape the industry's future.
Unlock exclusive insights with our detailed sample report (Please enter your Corporate Email ID to get priority access):- https://datamintelligence.com/download-sample/theranostics-market?rk
Theranostics is a cutting-edge approach in medicine that combines diagnostics and therapeutics into a single treatment strategy. It involves the use of specific biomarkers or diagnostic tests to identify and monitor diseases, followed by personalized treatments based on the information gathered. Theranostics is particularly impactful in areas like cancer treatment, where it enables tailored therapies to target cancer cells more precisely, improving treatment efficacy and minimizing side effects. The goal is to provide individualized medicine for more effective and efficient care.
List of the Key Players in the Theranostics Market:
GE Healthcare, Jubilant Pharmova Limited (Jubilant Pharma Limited), Theragnostics Ltd., NuView Life Sciences, Lantheus Holdings, Inc., CapVest Limited (Curium Pharma), Clarity Pharmaceuticals, Cardinal Health, LLC, Advanced Accelerator Applications, and ITM Isotopen Technologien München AG among others.
Theranostics Industry Development:
February 22, 2022: Theragnostics announced that NephroScan, its radiodiagnostic imaging drug designed to assist in evaluating renal parenchymal disorders in adult and pediatric patients, including term neonates, has received Marketing Approval from the US Food and Drug Administration (FDA).
February 10, 2022: Theragnostics, a company focused on developing radiopharmaceuticals for cancer imaging and treatment, revealed that its novel I-123 PARPi (THG-009) therapeutic agent has been granted an Innovation Passport by the UK Medicines and Healthcare Products Regulatory Agency (MHRA). The approval is for the treatment of primary and recurrent Glioblastoma Multiforme (GBM) under the MHRA's Innovative Licensing and Access Pathway (ILAP), aimed at accelerating the development and access to innovative medicines in the UK.
Research Methodology
Our research methodology combines both qualitative and quantitative approaches to provide you with a thorough market analysis. We begin by gathering data from trusted industry reports and databases (secondary research), followed by primary research through surveys and interviews with key experts. We then apply advanced statistical tools to analyze the data, uncover trends, and assess market dynamics. Additionally, we use market segmentation and Porter's Five Forces analysis to evaluate competition. This approach ensures that the insights we provide are reliable, actionable, and tailored to support your decision-making process.
Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/theranostics-market
Segment Covered in the Theranostics Market:
By Application: Oncology, Neurological Disorder, Cardiovascular Disease and Others
By Radioisotopes: Technetium-99, Gallium-68, Lutetium (Lu) 177, Iodine-131, Zirconium-89 , Y-90 and Others
By End User: Hospitals, Cancer Research Institutes, Diagnostic Centers and Others
This Report Covers:
✔ Go-to-market Strategy.
✔ Neutral perspective on the market performance.
✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.
✔Customized regional/country reports as per request and country level analysis.
✔ Potential & niche segments and regions exhibiting promising growth covered.
✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Regional Analysis for Theranostics Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Frequently asked questions:
➠ What is the global sales value, production value, consumption value, import and export of Theranostics market?
➠ Who are the global key manufacturers of the Theranostics Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?
➠ What are the Theranostics market opportunities and threats faced by the vendors in the global Theranostics Industry?
➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?
➠ What focused approach and constraints are holding the Theranostics market?
➠ What are the different sales, marketing, and distribution channels in the global industry?
Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Theranostics Market Outlook: Emerging Technologies and Regional Insights - Major Companies are GE Healthcare, Jubilant Pharmova Limited & Theragnostics Ltd. here
News-ID: 4055590 • Views: …
More Releases from DataM Intelligence 4market Research LLP
United States Anti-Depression Drugs Market to Reach $22.10B by 2031 - Driven by …
The Global Anti Depression Drugs Market reached US$ 15.81 billion in 2023 and is expected to reach US$ 22.10 billion by 2031, growing at a CAGR of 4.3% during the forecast period 2024-2031.
Anti-depression drugs are medications used to treat depressive disorders, including major depressive disorder, persistent depressive disorder, and treatment-resistant depression. These include selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), and atypical antidepressants. The market…
Power Module for EV Chargers Market to Hit $10.5M by 2031 - Driving Next-Gen EV …
Global Power Module for EV Charger Market reached US$ 2.0 Million in 2023 and is expected to reach US$ 10.5 Million by 2031, growing with a CAGR of 23.0% during the forecast period 2024-2031.
Power modules for EV chargers are critical electronic components that manage power conversion and distribution in electric vehicle (EV) charging stations. They ensure efficient, reliable, and safe transfer of electricity from the grid to the vehicle battery,…
Dystrophin Gene Therapy Market to Reach $12B by 2033 - Transforming Duchenne Mus …
Dystrophin Gene Therapy Market reached US$ 1.91 billion in 2024 and is expected to reach US$ 12.00 billion by 2033, growing at a CAGR of 20.6% during the forecast period 2025-2033.
Dystrophin gene therapy is a targeted treatment for Duchenne Muscular Dystrophy (DMD), a rare genetic disorder caused by mutations in the dystrophin gene. The therapy aims to restore or replace the defective dystrophin protein, slowing disease progression, improving muscle function,…
United States Anesthesia Disposables Market to Reach $1.83B by 2031 - Driven by …
The Global Anesthesia Disposables Market reached US$ 1.12 billion in 2023 and is expected to reach US$ 1.83 billion by 2031, growing at a CAGR of 6.4% during the forecast period 2024-2031.
Anesthesia disposables are single-use medical supplies used in anesthesia delivery, including breathing circuits, masks, endotracheal tubes, airway management devices, syringes, and catheters. The market is growing due to increasing surgical procedures worldwide, rising preference for single-use devices to prevent…
More Releases for Theranostics
Theranostics Market in 2025 Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Theranostics Market -(Product (Diagnostic imaging, Radiopharmaceuticals, Biomarker screening and Software), Application (Prostate Cancer, Bone Metastasis, Other Cancers, Other Application), End-user (Hospitals & Cancer Care Centers, Theranostics Centers, and Research & Academic Centers)) Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Theranostics Market Size is valued…
Rising Cancer Prevalence Fuels Growth In The Theranostics Market Driver: Leading …
What combination of drivers is leading to accelerated growth in the theranostics market?
The theranostics market is forecasted to grow due to an upward trend in cancer cases. Cancer, a disease characterized by unchecked cell growth affecting numerous organs, is a leading cause of considerable illness and death globally. Theranostics, combining therapeutic and diagnostic aspects, holds significant prospects in managing cancer and chronic illnesses. This methodology paves the way for tailored…
Theranostics Market worth $4.3 billion by 2028
The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall theranostics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies.
Theranostics Market [https://www.marketsandmarkets.com/Market-Reports/theranostics-market-111696976.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] in terms of revenue was estimated to be worth $2.1 billion in 2023 and is poised to reach $4.3…
Theranostics Market Worth $4.3 Billion | MarketsandMarkets Trademark
Theranostics Market in terms of revenue was estimated to be worth $2.1 billion in 2023 and is poised to reach $4.3 billion by 2028, growing at a CAGR of 15.5% from 2023 to 2028
Theranostics Market [https://www.marketsandmarkets.com/Market-Reports/theranostics-market-111696976.html?utm_source=Prnewswire&utm_medium=referral&utm_campaign=paidpr] in terms of revenue was estimated to be worth $2.1 billion in 2023 and is poised to reach $4.3 billion by 2028, growing at a CAGR of 15.5% from 2023 to 2028 according to…
Theranostics Market: Pioneering Precision Medicine into 2030
The Theranostics Market was valued USD 1.9 Billion in 2023 and projected to reach USD 5.4 Billion by 2030, growing at a CAGR of 16.2% during the forecast period of 2024-2030.
The Theranostics Market report studies the competitive environment of the Theranostics Market based on company profiles and their efforts to increase product value and production. The Theranostics Market report discusses various factors driving or restraining the market, which will help…
Theranostics Market Is Booming Worldwide Just Published
Global Theranostics Market: An Overview
Theranostics is a new field of medicine which relies on targeted therapies to conduct specific targeted tests. These tests are mainly used for various forms of cancers. The key concern in the therapeutics involve patient centric care with the help of more personalised and precise approach. The technique relies on the use of diagnostic and therapeutic applications to form a single agent. The system is known…
